China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)
13.25
-0.04 (-0.30%)
Nov 17, 2026, 3:04 PM CST
SHE:300294 Revenue
China Resources Boya Bio-pharmaceutical Group Co.,Ltd had revenue of 203.36M CNY in the quarter ending September 30, 2026, a decrease of -56.37%. This brings the company's total for the last twelve months to 1.43B, down -27.07% year-over-year. In the year 2025, China Resources Boya Bio-pharmaceutical Group Co.,Ltd had annual revenue of 2.06B with 18.69% growth. That makes China Resources Boya Bio-pharmaceutical Group Co.,Ltd the 17,013th largest company in the world by revenue and 3,092nd in China.
Revenue (ttm)
1.43B
Revenue Growth
-27.07%
P/S Ratio
4.69
Revenue / Employee
735.53K
Employees
1,947
Market Cap
6.68B
Revenue by Segment
- Blood Products Business 1.67B 81.2%
- Pharmaceutical Distribution Business 197.91M 9.6%
- Biochemical Pharmaceutical Product 181.66M 8.8%
- Other Business 8.49M 0.4%
Fiscal year ended Dec 31, 2025 See the full SHE:300294 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.06B | 324.18M | 18.69% |
| Dec 31, 2024 | 1.73B | -917.08M | -34.58% |
| Dec 31, 2023 | 2.65B | -106.72M | -3.87% |
| Dec 31, 2022 | 2.76B | 108.17M | 4.08% |
| Dec 31, 2021 | 2.65B | 137.49M | 5.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 16.13B |
| Novogene | 2.30B |
| Jiangxi Fushine Pharmaceutical | 1.97B |
| Aurisco Pharmaceutical | 1.67B |
| Chengdu Easton Biopharmaceuticals | 1.30B |
| Chengdu Kanghua Biological Products | 1.21B |
| Bio-Thera Solutions | 1.05B |
| Daan Gene | 776.43M |
China Resources Boya Bio-pharmaceutical Group Co.,Ltd News
- 19 days ago - China Resources Boya Bio-pharmaceutical Group Co.,Ltd Quarterly report: Q3 2026 - Filings
- 2 months ago - China Resources Boya Bio-pharmaceutical Group Co.,Ltd Quarterly report: H1 2026 - Filings
- 6 months ago - China Resources Boya Bio-pharmaceutical Group Co.,Ltd Quarterly report: Q1 2026 - Filings
- 8 months ago - China Resources Boya Bio-pharmaceutical Group Co.,Ltd Earnings release: H2 2025 - Filings
- 8 months ago - China Resources Boya Bio-pharmaceutical Group Co.,Ltd Annual report: H2 2025 - Filings